- Filed
- May 19, 2026 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Diluted | FY 2026 · Mar 31, 2026 | 426.58M sh |
| Shares Diluted | FY 2026 · Mar 31, 2025 | 432.25M sh |
| Shares Diluted | FY 2026 · Mar 31, 2024 | 451.01M sh |
| Stock Repurchased | FY 2026 · Mar 31, 2026 | $25M |
| Stock Repurchased | FY 2026 · Mar 31, 2025 | $90M |
| Stock Repurchased | FY 2026 · Mar 31, 2024 | $75M |
| Capex | FY 2026 · Mar 31, 2026 | $87.08M |
| Capex | FY 2026 · Mar 31, 2025 | $168.68M |
| Capex | FY 2026 · Mar 31, 2024 | $150.33M |
| Operating Cash Flow | FY 2026 · Mar 31, 2026 | −$75.09M |
| Operating Cash Flow | FY 2026 · Mar 31, 2025 | −$59.32M |
| Operating Cash Flow | FY 2026 · Mar 31, 2024 | $353.97M |
| Long Term Debt | FY 2026 · Mar 31, 2026 | $590.61M |
| Long Term Debt | FY 2026 · Mar 31, 2025 | $595.13M |
| Short Term Debt | FY 2026 · Mar 31, 2026 | $599.84M |
| Short Term Debt | FY 2026 · Mar 31, 2025 | $0 |
| Cash And Equivalents | FY 2026 · Mar 31, 2026 | $309.17M |
| Cash And Equivalents | FY 2026 · Mar 31, 2025 | $501.36M |
| Cash And Equivalents | FY 2026 · Mar 31, 2024 | $858.69M |
| Stockholders Equity | FY 2026 · Mar 31, 2026 | $1.41B |
| Stockholders Equity | FY 2026 · Mar 31, 2025 | $1.89B |
| Stockholders Equity | FY 2026 · Mar 31, 2024 | $2.15B |
| Stockholders Equity restated | FY 2026 · Mar 31, 2023 | $1.97B |
| Current Liabilities | FY 2026 · Mar 31, 2026 | $1.68B |
| Current Liabilities | FY 2026 · Mar 31, 2025 | $1.11B |
| Total Liabilities | FY 2026 · Mar 31, 2026 | $3B |
| Total Liabilities | FY 2026 · Mar 31, 2025 | $2.41B |
| Current Assets | FY 2026 · Mar 31, 2026 | $2.72B |
| Current Assets | FY 2026 · Mar 31, 2025 | $2.33B |
| Total Assets | FY 2026 · Mar 31, 2026 | $4.42B |
| Total Assets | FY 2026 · Mar 31, 2025 | $4.3B |
| Eps Diluted | FY 2026 · Mar 31, 2026 | −$1.16 |
| Eps Diluted | FY 2026 · Mar 31, 2025 | −$0.47 |
| Eps Diluted | FY 2026 · Mar 31, 2024 | $0.52 |
| Eps Basic | FY 2026 · Mar 31, 2026 | −$1.16 |
| Eps Basic | FY 2026 · Mar 31, 2025 | −$0.47 |
| Eps Basic | FY 2026 · Mar 31, 2024 | $0.53 |
| Sga Expense | FY 2026 · Mar 31, 2026 | $2.29B |
| Sga Expense | FY 2026 · Mar 31, 2025 | $2.6B |
| Sga Expense | FY 2026 · Mar 31, 2024 | $2.4B |
| Net Income | FY 2026 · Mar 31, 2026 | −$495.64M |
| Net Income | FY 2026 · Mar 31, 2025 | −$201.27M |
| Net Income | FY 2026 · Mar 31, 2024 | $232.04M |
| Operating Income | FY 2026 · Mar 31, 2026 | −$163.11M |
| Operating Income | FY 2026 · Mar 31, 2025 | −$185.22M |
| Operating Income | FY 2026 · Mar 31, 2024 | $229.75M |
| Gross Profit | FY 2026 · Mar 31, 2026 | $2.26B |
| Gross Profit | FY 2026 · Mar 31, 2025 | $2.47B |
| Gross Profit | FY 2026 · Mar 31, 2024 | $2.63B |
| Cost Of Revenue | FY 2026 · Mar 31, 2026 | $2.71B |
| Cost Of Revenue | FY 2026 · Mar 31, 2025 | $2.69B |
| Cost Of Revenue | FY 2026 · Mar 31, 2024 | $3.07B |
| Revenue | FY 2026 · Mar 31, 2026 | $4.97B |
| Revenue | FY 2026 · Mar 31, 2025 | $5.16B |
| Revenue | FY 2026 · Mar 31, 2024 | $5.7B |